Loading...
Docoh
Log in Free sign up

Mosaic ImmunoEngineering (CPMV)

Patriot Scientific Corp. is a intellectual property licensing company with several patents, which design and development of microprocessor chips design. Its technologies are used in computers, cameras, printers, automotive and industrial devices. The company was founded on June 10, 1987 and is headquartered in Carlsbad, CA.

Company profile

Ticker
CPMV
Exchange
OTC
Website
www.ptsc.com/
CEO
Carlton Johnson
Employees
Incorporated
Delaware
Location
California
Fiscal year end
Dec 31
Sector
Real Estate and Rental and Leasing > Lessors of Nonfinancial Intangible Assets (except Copyrighted Works)
Industry (SIC)
Biological Products, (No Diagnostic Substances)
AMGEN • Gilead Sciences • Biogen • Qiagen • Moderna • BioNTech SE • Sana Biotechnology • Ginkgo Bioworks • Bio-Techne • Denali Therapeutics ...
Former names
PATRIOT SCIENTIFIC CORP
SEC CIK
0000836564
Corporate docs
Subsidiaries
Mosaic ImmunoEngineering Development Company • Patriot Data Solutions Group, Inc. ...
IRS number
841070278

CPMV stock data

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

4 Aug 22
12 Aug 22
31 Dec 22

Financial summary

Financial statements Chart CPMV financial data
Quarter (USD) Jun 22 Mar 22 Dec 21 Sep 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 May 20 May 19 May 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 205.99K 205.99K 205.99K 205.99K 205.99K 205.99K
Cash burn (monthly) 57.35K 31.36K 294.58K 290.47K 57.35K 59.83K
Cash used (since last report) 83.11K 45.44K 426.88K 420.94K 83.11K 86.7K
Cash remaining 122.88K 160.55K -220.89K -214.94K 122.88K 119.29K
Runway (months of cash) 2.1 5.1 -0.7 -0.7 2.1 2.0

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Recent insider trades

CPMV insider ownership history Insider history
Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
18 Feb 22 Nicole Franziska Steinmetz Convertible Note [object Object] Other Acquire J No No 10000 - 10K -
18 Feb 22 Robert Baffi Convertible Note [object Object] Other Acquire J No No 50000 - 50K -
18 Feb 22 Robert L Garnick Convertible Note [object Object] Other Acquire J No No 50000 - 50K -
18 Feb 22 King Steven W Convertible Note [object Object] Other Acquire J No No 20000 - 20K -
18 Feb 22 Gloria Felcyn Convertible Note [object Object] Other Acquire J Yes No 25000 - 25K -
Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

Institutional ownership, Q1 2022

CPMV institutional ownership history Ownership history
13F holders Current Prev Q Change
Total holders 2 1 +100.0%
Opened positions 1 0 NEW
Closed positions 0 1 EXIT
Increased positions 0 0
Reduced positions 0 0
13F shares Current Prev Q Change
Total value 0 0
Total shares 4.01B 4.01B +0.0%
Total puts 0 0
Total calls 0 0
Total put/call ratio – – –
Largest owners Shares Value Change
Western Reserve University Case 4.01B $0 0.0%
West Oak Capital 1 $0 NEW
Largest transactions Shares Bought/sold Change
West Oak Capital 1 +1 NEW
Western Reserve University Case 4.01B 0 0.0%
Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Financial report summary

?
Competition
Bristol-Myers Squibb • Pfizer • AMGEN • Astrazeneca • Nektar Therapeutics • Novartis • Sanofi • GSK • BioNTech SE

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. senior Avg
New words: calendar, expedite, fifteen, foregoing, Holocom, Jonathan, month, Notwithstanding, Pokorski, redeem, redeemable, redeemed, thirty, transmitted
Removed: absence, absolute, accurately, aim, assure, capitalization, implementation, implemented, maintained, predicted, promulgated, ranging, ratio, reduction, split, view
From filing 10-Q 2022 Q2
Financial reports
View all
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
10 May 22
10-K
2021 FY
Annual report
25 Jan 22
10-Q
2021 Q3
Quarterly report
2 Nov 21
10-Q
2021 Q2
Quarterly report
3 Aug 21
10-Q
2021 Q1
Quarterly report
5 May 21
10-KT
2020 FY
Filing
2 Mar 21
10-Q
2021 Q2
Quarterly report
29 Dec 20
10-Q
2021 Q1
Quarterly report
15 Oct 20
10-K
2020 FY
Annual report
24 Aug 20
Current reports
View all
8-K
Entry into a Material Definitive Agreement
12 Jul 22
8-K
Mosaic ImmunoEngineering Announces Completion of Exclusive Technology License Agreement with Case Western Reserve University
5 May 22
8-K
Entry into a Material Definitive Agreement
22 Feb 22
8-K
Mosaic ImmunoEngineering Inc. Elects Biotechnology Industry Veteran Robert A. Baffi, Ph.D. to Its Board of Directors
15 Jun 21
8-K
Entry into a Material Definitive Agreement
10 May 21
8-K
Amendments to Articles of Incorporation or Bylaws
30 Dec 20
8-K
Material Modifications to Rights of Security Holders
1 Dec 20
8-K/A
Departure of Directors or Certain Officers
19 Nov 20
8-K/A
Index to Financial Statements
14 Oct 20
8-K
Patriot Scientific Corporation and Mosaic ImmunoEngineering Inc. Enter into Definitive Merger Agreement
25 Aug 20
Registration and prospectus
View all
S-1
IPO registration
3 Feb 22
S-8
Registration of securities for employees
9 Mar 21
S-3/A
Shelf registration (amended)
21 Jan 21
S-3
Shelf registration
10 Dec 20
D
$3.75K in options / securities to be acquired, sold $3.75K, 1 investor
25 Jan 10
S-8
Registration of securities for employees
1 Apr 09
S-8
Registration of securities for employees
27 Mar 08
POS AM
Prospectus update (post-effective amendment)
25 Dec 07
SB-2/A
Registration of securities for small business issuer (amended)
1 Apr 07
SB-2/A
Registration of securities for small business issuer (amended)
20 Mar 07
Proxies
View all
DEF 14C
Information statement
25 Jun 21
PRE 14C
Preliminary information
15 Jun 21
DEF 14C
Information statement
2 Nov 20
PRE 14C
Preliminary information
23 Oct 20
DEF 14A
Definitive proxy
17 Apr 18
DEFA14A
Additional proxy soliciting materials
17 Apr 18
DEF 14A
Definitive proxy
14 Mar 17
DEF 14A
Definitive proxy
17 Mar 16
PRE 14A
Preliminary proxy
7 Mar 16
DEF 14A
Definitive proxy
8 Mar 15
Other
View all
EFFECT
Notice of effectiveness
1 Feb 21
CORRESP
Correspondence with SEC
24 Jan 21
CORRESP
Correspondence with SEC
20 Jan 21
UPLOAD
Letter from SEC
20 Dec 20
CT ORDER
Confidential treatment order
25 Sep 16
CT ORDER
Confidential treatment order
4 Jan 15
CT ORDER
Confidential treatment order
15 Sep 14
CT ORDER
Confidential treatment order
13 Feb 13
NO ACT
No action letter
17 Oct 10
NO ACT
No action letter
28 Sep 10
Ownership
View all
4
Mosaic ImmunoEngineering / STEVEN W KING ownership change
22 Feb 22
4
Mosaic ImmunoEngineering / GLORIA FELCYN ownership change
22 Feb 22
4
Mosaic ImmunoEngineering / ROBERT L GARNICK ownership change
22 Feb 22
4
Mosaic ImmunoEngineering / ROBERT BAFFI ownership change
22 Feb 22
4
Mosaic ImmunoEngineering / Nicole Franziska Steinmetz ownership change
22 Feb 22
3
Mosaic ImmunoEngineering / ROBERT BAFFI ownership change
16 Jul 21
4
Mosaic ImmunoEngineering / ROBERT L GARNICK ownership change
10 May 21
4
Mosaic ImmunoEngineering / GLORIA FELCYN ownership change
10 May 21
4
Mosaic ImmunoEngineering / Nicole Franziska Steinmetz ownership change
30 Apr 21
4
Mosaic ImmunoEngineering / Nicole Franziska Steinmetz ownership change
29 Jan 21